Literature DB >> 10320667

Guanylate cyclase and the .NO/cGMP signaling pathway.

J W Denninger1, M A Marletta.   

Abstract

Signal transduction with the diatomic radical nitric oxide (NO) is involved in a number of important physiological processes, including smooth muscle relaxation and neurotransmission. Soluble guanylate cyclase (sGC), a heterodimeric enzyme that converts guanosine triphosphate to cyclic guanosine monophosphate, is a critical component of this signaling pathway. sGC is a hemoprotein; it is through the specific interaction of NO with the sGC heme that sGC is activated. Over the last decade, much has been learned about the unique heme environment of sGC and its interaction with ligands like NO and carbon monoxide. This review will focus on the role of sGC in signaling, its relationship to the other nucleotide cyclases, and on what is known about sGC genetics, heme environment and catalysis. The latest understanding in regard to sGC will be incorporated to build a model of sGC structure, activation, catalytic mechanism and deactivation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10320667     DOI: 10.1016/s0005-2728(99)00024-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  221 in total

1.  Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses.

Authors:  T C Bellamy; J Wood; D A Goodwin; J Garthwaite
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Neural network partitioning by NO and cGMP.

Authors:  N L Scholz; J de Vente; J W Truman; K Graubard
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

3.  Unprecedented proximal binding of nitric oxide to heme: implications for guanylate cyclase.

Authors:  D M Lawson; C E Stevenson; C R Andrew; R R Eady
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

4.  Progress report on molecular biometallics (1996-2000), a project of the priority areas for research under the auspices of the Japanese Government.

Authors:  T Kitagawa
Journal:  J Biol Inorg Chem       Date:  2000-06       Impact factor: 3.358

Review 5.  Soluble guanylate cyclases in the retina.

Authors:  Ari Sitaramayya
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

6.  The case of CO signaling: why the jury is still out.

Authors:  S P Cary; M A Marletta
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 7.  Nitric oxide and its role in blastocyst implantation.

Authors:  Omid Khorram
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

8.  Synaptic localization of nitric oxide synthase and soluble guanylyl cyclase in the hippocampus.

Authors:  Alain Burette; Ulrike Zabel; Richard J Weinberg; Harald H H W Schmidt; Juli G Valtschanoff
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

9.  Nitric oxide inhibits isoproterenol-stimulated adipocyte lipolysis through oxidative inactivation of the beta-agonist.

Authors:  P Klatt; J Cacho; M D Crespo; E Herrera; P Ramos
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

10.  Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells.

Authors:  Vladan P Cokic; Silvana A Andric; Stanko S Stojilkovic; Constance T Noguchi; Alan N Schechter
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.